CAS 329216-65-1
:2-[2-[4-(5,5-Diossido di dibenzo[b,f][1,4]tiazepin-11-il)-1-piperazinil]etossi]etanolo
- 2-[2-[4-(5,5-Dioxidodibenzo[b,f][1,4]thiazepin-11-yl)-1-piperazinyl]ethoxy]ethanol
- Ethanol, 2-[2-[4-(5,5-dioxidodibenzo[b,f][1,4]thiazepin-11-yl)-1-piperazinyl]ethoxy]-
Ref: 4Z-Q-0119
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaQuetiapine Sulfone-d8
CAS:Prodotto controllatoFormula:C21D8H17N3O4SColore e forma:NeatPeso molecolare:423.555Quetiapine Sulfone
CAS:Prodotto controllatoImpurity Quetiapine Sulfone Impurity
Applications An impurity of the antipsychotic Quetiapine (Q510000).
References Warawa, E.J. et al.: J. Med. Chem., 44, 372 (2001);Formula:C21H25N3O4SColore e forma:NeatPeso molecolare:415.512-[2-[4-(5,5-Dioxidodibenzo[b,f][1,4]thiazepin-11-yl)-1-piperazinyl]ethoxy]ethanol
CAS:Quetiapine is a drug that belongs to the class of sulfoxides. It is usually administered orally, but can also be given intravenously or intramuscularly. Quetiapine has been studied for its clinical use in the treatment of schizophrenia and bipolar disorder. The plasma concentrations of quetiapine are determined by high-performance liquid chromatography (HPLC) with tandem mass spectrometry (LC-MS/MS) detection. Validation studies have shown that the HPLC-MS/MS method is accurate and precise, with good linearity over a range of concentrations. Analysis was performed on plasma samples from healthy volunteers who were administered either 2 mg or 10 mg doses of quetiapine by intravenous injection. Concentrations were calculated and compared to those found in patients with schizophrenia and bipolar disorder who had been given oral doses of 300 mg per day for four weeks, yielding a therapeutic plasma concentration range from 100 to 300 ng/mL.
Formula:C21H25N3O4SPurezza:Min. 95%Peso molecolare:415.51 g/mol



